ChartMill assigns a Buy % Consensus number of 43% to LJPC. The Buy consensus is the weighted average rating of the current analysts ratings.
6 analysts have analysed LJPC and the average price target is 6.35 USD. This implies a price increase of 2.16% is expected in the next year compared to the current price of 6.22.
The consensus rating for LA JOLLA PHARMACEUTICAL CO (LJPC) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering LA JOLLA PHARMACEUTICAL CO (LJPC) is 6.